Alder BioPharma's migraine drug succeeds in mid-stage study

(Reuters) - Alder BioPharmaceuticals Inc said on Monday its drug to prevent migraines had met the main goal in a keenly watched mid-stage study.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro